Cargando…

Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer

Hyperactivation of the epidermal growth factor receptor (EGFR) pathways and chronic inflammation are common characteristics of oral squamous cell carcinoma (OSCC). Previously, we reported that OSCC cells secrete interleukin-1 beta (IL-1β), which promotes the proliferation of the oral premalignant ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chia-Huei, Syu, Shih-Han, Liu, Ko-Jiunn, Chu, Pei-Yi, Yang, Wen-Chan, Lin, Pinpin, Shieh, Wan-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770743/ https://www.ncbi.nlm.nih.gov/pubmed/26462152

Ejemplares similares

CXCL1/CXCR2 Paracrine Axis Contributes to Lung Metastasis in Osteosarcoma
por: Chao, Chia-Chia, et al.
Publicado: (2020)

CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020)

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
por: Ha, Helen, et al.
Publicado: (2017)

Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
por: Han, Zhi-Jian, et al.
Publicado: (2021)

Role of the transcription factor Fli-1 on the CXCL10/CXCR3 Axis*
por: Wang, Xuan, et al.
Publicado: (2023)

Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties
por: Vacchini, Alessandro, et al.
Publicado: (2018)

Interleukin-1 receptor antagonist inhibits matastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer
por: Ma, Jiachi, et al.
Publicado: (2021)

Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma
por: Kasashima, Hiroaki, et al.
Publicado: (2017)

CXCL12-CXCR4 axis in feline mammary carcinoma
por: Ferreira, Fernando
Publicado: (2017)

Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
por: Pan, Zijian, et al.
Publicado: (2022)

Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
por: Liberman, Julie, et al.
Publicado: (2012)

CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
por: Wu, Xia, et al.
Publicado: (2023)

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications
por: Yang, Yaru, et al.
Publicado: (2023)

CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015)

CXCR3-CXCL11 axis: recruiting macrophages in mycobacterial infection
Publicado: (2015)

Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment
por: Tan, Ping, et al.
Publicado: (2018)

Corrigendum: Role of the CXCL13/CXCR5 axis in autoimmune diseases
por: Pan, Zijian, et al.
Publicado: (2022)

CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3
por: Feng, Weibo, et al.
Publicado: (2021)

Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review
por: Nazari, Alireza, et al.
Publicado: (2020)

CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR
por: Circelli, Luisa, et al.
Publicado: (2016)

CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma
por: Werner, Thomas A, et al.
Publicado: (2017)

Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate
por: Murad, Hussam A. S., et al.
Publicado: (2021)

The ELR(+)CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma
por: Giuliano, Sandy, et al.
Publicado: (2014)

Epidermal Growth Factor Protects Squamous Cell Carcinoma against Cisplatin-Induced Cytotoxicity through Increased Interleukin-1β Expression
por: Ko, Shian-Chin, et al.
Publicado: (2013)

The CXCL8-CXCR1/2 pathways in cancer
por: Liu, Qian, et al.
Publicado: (2016)

Back From the Brink: The Uses of Targeting the CXCL10:CXCR3 Axis in Type 1 Diabetes
por: Homann, Dirk
Publicado: (2015)

MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis
por: Chen, Lei, et al.
Publicado: (2021)

Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1‐CXCR2 axis
por: Hayashi, Masataka, et al.
Publicado: (2023)

MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis
por: Chen, Lei, et al.
Publicado: (2023)

CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
por: Khare, Tripti, et al.
Publicado: (2021)

The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
por: Döring, Yvonne, et al.
Publicado: (2014)

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
por: Cojoc, Monica, et al.
Publicado: (2013)

The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
por: García-Cuesta, Eva M., et al.
Publicado: (2019)

CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer
por: Guo, Jun-Chao, et al.
Publicado: (2016)

Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma
por: Xue, Li‐Jun, et al.
Publicado: (2017)

CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2015)

The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells
por: Ruffini, Pier Adelchi
Publicado: (2019)

Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
por: Liu, Guangchen, et al.
Publicado: (2019)

The CXCL1-CXCR2 Axis Mediates Tubular Injury in Diabetic Nephropathy Through the Regulation of the Inflammatory Response
por: Tang, Hanfen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iodhlibpvoapmp573l67jeoka5